hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy

BACKGROUND: The identification of early-stage colorectal cancer (CRC) with high risk of progression is one major clinical challenge, mainly due to lack of validated biomarkers. The aims of the present study were to analyze the prognostic impact of three molecular markers belonging to the ion channel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Muratori, Leonardo, Petroni, Giulia, Antonuzzo, Lorenzo, Boni, Luca, Iorio, Jessica, Lastraioli, Elena, Bartoli, Gianluca, Messerini, Luca, Di Costanzo, Francesco, Arcangeli, Annarosa
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5072508/
https://ncbi.nlm.nih.gov/pubmed/27789963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S114090
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados